Cargando…
Secondary neoplasms of the urinary bladder-clinical management and oncological outcomes
BACKGROUND: Secondary neoplasms of the bladder account for 4.5% of all bladder neoplasms however there is limited literature reporting management and survival. This is the largest single centre series presented in current literature with long term oncological follow up. METHODS: This is a single ins...
Autores principales: | El-Taji, Omar, Al-Mitwalli, Abdullah, Malik, Farhan, Agarwal, Samita, Gogbashian, Andrew, Hughes, Rob, Vasdev, Nikhil, Sharma, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261409/ https://www.ncbi.nlm.nih.gov/pubmed/34295729 http://dx.doi.org/10.21037/tau-20-955 |
Ejemplares similares
-
A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell Tumors
por: Sharma, Anand, et al.
Publicado: (2022) -
Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
por: Arianayagam, Ranjan, et al.
Publicado: (2018) -
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020) -
Biomarkers in Bladder Cancer Surveillance
por: Sugeeta, Sukumar S., et al.
Publicado: (2021) -
Single tertiary cancer center experience on the management of pT3b prostate cancer after robotic-assisted laparoscopic prostatectomy
por: Nayak, Arvind, et al.
Publicado: (2022)